Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
about
Emerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and MechanismsEndothelial dysfunction and coronary artery disease: assessment, prognosis, and treatmentInterplay between Oxidative Stress and Nutrient Sensing Signaling in the Developmental Origins of Cardiovascular Disease.Vitamin D supplementation lowers thrombospondin-1 levels and blood pressure in healthy adultsInhibition of calpain reduces oxidative stress and attenuates endothelial dysfunction in diabetes.N(ω)-NITRO-N(ω')-SUBSTITUTED GUANIDINES: A SIMPLE CLASS OF NITRIC OXIDE SYNTHASE INHIBITORS.Effects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion.Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension.Effects of Electroacupuncture Stimulation at "Zusanli" Acupoint on Hepatic NO Release and Blood Perfusion in MiceResistin increases monolayer permeability of human coronary artery endothelial cells.Effects of ischemic preconditioning on the systemic and renal hemodynamic changes in renal ischemia reperfusion injury.Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromesCaloric restriction induces heat shock response and inhibits B16F10 cell tumorigenesis both in vitro and in vivoTPEN prevents rapid pacing-induced calcium overload and nitration stress in HL-1 myocytes.Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction.Metabolic origins of childhood asthma.Biphasic Effect of Diabetes on Neuronal Nitric Oxide Release in Rat Mesenteric ArteriesComparative proteome analysis of abdominal adipose tissues between fat and lean broilers.A potent anti-inflammatory peptide from the salivary glands of horsefly.Pulmonary Protection Strategies in Cardiac Surgery: Are We Making Any Progress?Soy Isoflavone Protects Myocardial Ischemia/Reperfusion Injury through Increasing Endothelial Nitric Oxide Synthase and Decreasing Oxidative Stress in Ovariectomized Rats.Redox signaling in pathophysiology of hypertension.Modeling Disease Progression: Angiotensin II Indirectly Inhibits Nitric Oxide Production via ADMA Accumulation in Spontaneously Hypertensive Rats.Critical role of vascular peroxidase 1 in regulating endothelial nitric oxide synthase.Molecular characterization of reactive oxygen species in systemic and pulmonary hypertension.Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model.Diabetes and the brain: oxidative stress, inflammation, and autophagy.Homocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur.Heart failure with preserved ejection fraction: Defining the function of ROS and NO.Clinical Significance of Endothelial Dysfunction in Essential Hypertension.Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes.Glucose Homeostasis and Cardiovascular Alterations in Diabetes.Effect of Oxidative Stress on Cardiovascular System in Response to Gravity.Sulfiredoxin-1 protects against simulated ischaemia/reperfusion injury in cardiomyocyte by inhibiting PI3K/AKT-regulated mitochondrial apoptotic pathways.Cryptotanshinone and wogonin up-regulate eNOS in vascular endothelial cells via ERα and down-regulate iNOS in LPS stimulated vascular smooth muscle cells via ERβ.Hp: an inflammatory indicator in cardiovascular disease.Role of Magnesium in Oxidative Stress in Individuals with Obesity.The role of NOS-mediated ROS accumulation in an early phase Cu-induced acute cytotoxicity in MCF-7 cells.Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients.Antioxidant therapy for management of oxidative stress induced hypertension.
P2860
Q26747066-83AA2F41-C138-4CE7-8A58-B71D76D97411Q26853087-FAFB43F7-BF38-4B04-878D-C09B46D3F4EAQ30234757-D79F7452-6AAB-412A-B3AD-9964D58A756CQ33657136-3FC4CBC8-6AE7-4831-970B-05C9B3CEFEF2Q33712788-ABFD733B-0596-4CAC-B5FD-57FCD046BC59Q34406163-E22AFBCE-CCCF-4DC8-9FAE-1AC399FDCB5EQ34562019-F67A40FB-F67A-448C-8902-ABB0E19795E6Q34886548-6F86DC85-82BD-41BF-9F8C-91588C358BF6Q35013070-0513A845-2C4C-4B95-9F4F-CF4B56C9CD7FQ35080983-1420BE30-5B9A-4C5B-8971-D10B6B0E39CCQ35405575-BAACB2DD-3C39-49E9-BFC3-5810E6B3FDE2Q35547367-567D8233-125B-4752-8391-EABB5C03E586Q35598545-58C98B9F-A50B-4AC6-8EBB-38583D21661EQ35631361-019EDE33-320A-4725-8BBC-E073E5E4D8D3Q35686992-F1C3D778-B016-4239-B078-9F440F1517CFQ35933300-F92DB4E1-E797-4CF8-B85B-6C5811B844D4Q36044063-F65A1C58-2E44-4129-8C0F-E605521F8024Q36122992-A0A15671-681A-4FF9-976B-D9A61A19DE59Q36203106-96C2CD1A-A6B3-4E21-BD2F-BF0A733C30C5Q36241538-354FB3A2-DB32-4EFD-98CD-66D2C23AB4DAQ36579199-8AB90303-0A65-4EBC-9592-4EE344C77226Q37273310-9186AC53-A77B-4DBC-8563-222C5DF0F44CQ37418608-5C0AD397-B844-45F6-975A-DECD929DAAE3Q37682579-E7908475-D8E1-4C33-841F-9BC4884D092CQ38189533-A9135FFD-7B37-48CC-A1D2-5D54F5EAF0D4Q38194032-DC289039-D901-422B-AC24-9D40355670F0Q38248610-054BF2F6-5BA6-42F3-B3C4-DDC34DC6C413Q38266911-93809062-5C2A-4688-B716-10E0E5F27A3FQ38482322-4728B670-074B-44C7-B0A6-30DC9E36A55BQ38586940-F117F24D-786F-4EF2-9D97-F0B98699E912Q38592775-89A9D007-C1FF-418D-9198-E5AB937E1E90Q38596700-A3DA570A-09C9-4937-BB08-4F79BC9CD0BAQ38662730-DCFAFAC4-AA3D-4EC4-BD06-0AEB336A5CB0Q38785056-5942C6C8-968F-448E-8730-1682D33A9B0BQ38826766-46D698D0-C6E6-4034-9EF9-94054863BA49Q38864675-9F154620-B7D8-4E3A-B179-8F531B3C8437Q38904965-BF45FB54-5D52-4946-B31B-284FFFE10BC4Q38939861-844CB8D7-962E-4C64-83F3-3F8819459170Q38952110-F373A8F5-9B7C-4850-9B0D-99E758F5BCA3Q39252696-0B92A09D-034F-41EA-80F4-79B12E3B32E8
P2860
Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nitric oxide synthase inhibiti ...... possible therapeutic targets?
@en
type
label
Nitric oxide synthase inhibiti ...... possible therapeutic targets?
@en
prefLabel
Nitric oxide synthase inhibiti ...... possible therapeutic targets?
@en
P2093
P1476
Nitric oxide synthase inhibiti ...... possible therapeutic targets?
@en
P2093
Catherine Vergely
Jean-Claude Guilland
Julie Lorin
Luc Lorgis
Marianne Zeller
P304
P356
10.1016/J.PHARMTHERA.2013.07.004
P577
2013-07-13T00:00:00Z